David Brown, DO | |
13001 E 17th Pl, Aurora, CO 80045-2570 | |
(303) 724-9424 | |
Not Available |
Full Name | David Brown |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 8 Years |
Location | 13001 E 17th Pl, Aurora, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396112694 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | DR.0062177 (Colorado) | Primary |
2084P0800X | Psychiatry & Neurology - Psychiatry | TL.0006136 (Colorado) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Colorado Hospital Authority | Aurora, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Physicians Incorporated | 3476465667 | 2657 |
News Archive
The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, which has just been published in the scientific journal Annals of Family Medicine.
A new study describes the identification of new compounds from a library, with inhibitory activity against several coronaviruses. This study shows the utility of this method, besides identifying compounds that not only inhibit viral shedding in SARS-CoV-2 cultures, but have an immunomodulatory effect that may be useful in mitigating the damaging cytokine storm typical of severe or critical COVID-19.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
A new study concludes that the unavailability of health insurance prior to Medicaid enrollment may contribute to poor outcomes in the Medicaid-insured cancer population.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at $7.00 per share, before underwriting discounts and commissions.
› Verified 5 days ago
Entity Name | University Physicians Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, which has just been published in the scientific journal Annals of Family Medicine.
A new study describes the identification of new compounds from a library, with inhibitory activity against several coronaviruses. This study shows the utility of this method, besides identifying compounds that not only inhibit viral shedding in SARS-CoV-2 cultures, but have an immunomodulatory effect that may be useful in mitigating the damaging cytokine storm typical of severe or critical COVID-19.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
A new study concludes that the unavailability of health insurance prior to Medicaid enrollment may contribute to poor outcomes in the Medicaid-insured cancer population.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at $7.00 per share, before underwriting discounts and commissions.
› Verified 5 days ago
Entity Name | University Of Colorado Hospital Authority |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1982944054 PECOS PAC ID: 1052223724 Enrollment ID: O20131014000076 |
News Archive
The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, which has just been published in the scientific journal Annals of Family Medicine.
A new study describes the identification of new compounds from a library, with inhibitory activity against several coronaviruses. This study shows the utility of this method, besides identifying compounds that not only inhibit viral shedding in SARS-CoV-2 cultures, but have an immunomodulatory effect that may be useful in mitigating the damaging cytokine storm typical of severe or critical COVID-19.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
A new study concludes that the unavailability of health insurance prior to Medicaid enrollment may contribute to poor outcomes in the Medicaid-insured cancer population.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at $7.00 per share, before underwriting discounts and commissions.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
David Brown, DO 13001 E 17th Place, Bldg 500, Ms-f546, Aurora, CO 80045-2578 Ph: () - | David Brown, DO 13001 E 17th Pl, Aurora, CO 80045-2570 Ph: (303) 724-9424 |
News Archive
The psychological strain of being told that you may have breast cancer may be severe, even if it turns out later to be a false alarm. This is the finding of new research from the University of Copenhagen, which has just been published in the scientific journal Annals of Family Medicine.
A new study describes the identification of new compounds from a library, with inhibitory activity against several coronaviruses. This study shows the utility of this method, besides identifying compounds that not only inhibit viral shedding in SARS-CoV-2 cultures, but have an immunomodulatory effect that may be useful in mitigating the damaging cytokine storm typical of severe or critical COVID-19.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
A new study concludes that the unavailability of health insurance prior to Medicaid enrollment may contribute to poor outcomes in the Medicaid-insured cancer population.
Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at $7.00 per share, before underwriting discounts and commissions.
› Verified 5 days ago
Lea C Watson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1890 N Revere Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Robert House, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Ann Olincy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Paul Moe, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Erin Schwarz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1537 Alton St, Aurora, CO 80010 Phone: 303-617-2300 | |
Robert Clyman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Bishara Bhasi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |